- This event has passed.
Informatics Research Seminar: The Role of Data in Precision Oncology
August 28 @ 4:00 pm - 5:00 pm EDT
Speaker: Warren A. Kibbe, PhD, FACMI
Presented from Duke
Broadcast Link: Seminar
At Duke, all seminars live or broadcast will be held in Hock Auditorium from 4-5 pm.
The promise of precision medicine in oncology is predicated on the availability of accurate, high quality data from the clinic and the laboratory. Likewise, a Learning Health System is one in which we use data to monitor that we are following guidelines and care pathways to deliver the best care and not revert to prior practices (regression testing for care!) and also provide real world evidence to determine effectiveness and identify populations that would benefit from novel therapies. Into this mix of clinical drivers are the rapidly changing capabilities in instrumentation, computing, data science, and the pervasive use of sensors and smart devices – many of which have health applications. A few of the opportunities will be highlighted in leveraging the increasingly digital landscape in healthcare and biomedical research as we move toward a learning health system for cancer.
Warren A. Kibbe, PhD, FACMI is the chief for Translational Biomedical Informatics in the Department of Biostatistics and Bioinformatics, Chief Data Officer for the Duke Cancer Institute and Director of the Bioinformatics Core for the Clinical & Translational Sciences Institute (CTSI). He joined the Duke University School of Medicine in August of 2017 after serving as the acting Deputy Director of the National Cancer Institute (NCI) and Director of the NCI’s Center for Biomedical Informatics and Information Technology where he oversaw 60 federal employees and more than 600 contractors, and served as an acting Deputy Director for NCI. As an acting Deputy Director, Dr. Kibbe was involved in the myriad of activities that NCI oversees as a research organization, as a convening body for cancer research, and as a major funder of cancer research, funding nearly $4B US annually in cancer research throughout the United States.